Therapeutic and imaging capacity of tumor-localizing radiosensitive Mn-porphyrin on SCCVII tumor-hearing C3H/He mice

Anti-Cancer Drugs

Volumn 8, Issue 4, 1997, Pages 386-390

  Nakajima, Susumu ^a   Shigemi, Nishibe ^a   Murakami, Noboru ^a   Aburano, Tamio ^a   Sakata, Isao ^b   Maruyama, Izumi ^b   Inoue, Makiko ^b   Takemura, Takeshi ^c  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

^b Toyohakka Kogyo   (Japan)

^c HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Hypoxic radiosensitizer; Imaging agent; Low neuro toxicity; Mn porphyrin; Tumor localizing agent

Indexed keywords

KADTF; PORPHYRIN DERIVATIVE; RADIOSENSITIZING AGENT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLONOGENIC ASSAY; CONTROLLED STUDY; GROWTH INHIBITION; HUMAN; HUMAN CELL; HYPOXIA; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCINTISCANNING; SQUAMOUS CELL CARCINOMA;

EID: 0030962919     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-199704000-00012     Document Type: Article

References (18)

1. Thomlinson RH, Gray LH. The histological structure of some human lung cancers and possible implications for radiotherapy. BrJ Cancer 1955; 9: 539-49.
2. Dishe S. Chemical sensitizers for hypoxic cells: a decade of experiences in clinical radiotherapy. Radiother Oncol 1985; 3; 97-115.
3. Overgaard J. Sensitization of hypoxic tumor cells-clinical experience. Int J Radiat Biol 1989; 56: 801-11.
4. Policard A. Etude sur les aspects offerts par des tumeurs experimentales examinëes ä la lumier de Wood. Compt Rend Soc Biol 1924; 91: 1423-4.
5. Dougherty TJ, Kaufman JH, Goldfarb A, Weinhaupt KR, Royle D, Mittleman A. Photo radiation therapy for the treatment of malignant tumors. Cancer Res 1978; 38: 3628-35.
6. Nakajima S, Hayashi H, Omote Y, et al. The tumor localizing properties of porphyrin derivatives. J Photochem Photobiol B: Biol 1990; 7: 189-98.
7. Nakajima S, Sakata I, Omote Y, et al. Detection and quantitative estimation of metalloporphyrins in vivo. J Photochem Photobiol, B: Biol 1991; 8: 409-17.
8. 111In-labeled Mn-metalloporphyrin for tumor imaging. Nucl Med Biol 1993; 20: 231-7.
9. Nakajima S, Hayashi H, Miyata T, Tanaka K, Sakata I, Takemura T. Tumor-localizing Mn metalloporphyrin for magnetic resonance imaging. Oncologia 1993; 26: 242-4.
10. Nakajima S, Sakata I, Takemura T. Tumor-localizing and photo sensitization of photochlorin ATX-S10. In: Spinelli P, Fante D, eds. Photodynamic therapy and biomedical lasers. Amsterdam: Elsevier Science 1992: 531-4.
11. Shibamoto Y, Nishimoto S, Shinokawa K, et al. Characteristics of fluorinated nitroazoles as hypoxic cell radiosensitizer: I. J Radiat Oncol 1989; 16: 1045-8.
12. Sasai K, Nishimoto S, Shimozawa K, et al. A fluorinated 2-nitroimidazole, KU-2285, as a new hypoxic cell radiosensitizer. I. J Radiat Oncol 1991; 20: 1249-54.
13. Shibamoto Y, Sasai K, Sakaguchi M, et al. Evaluation of a new 2-nitroimidazole nucleoside analogue, RK-28 as a radiosensitizer for clinical use. Int J Radiat Biol 1991; 59: 105-15.
14. Shibamoto Y, Sasaki K, Abe M. The radiation responce of SCCVII tumor cells in C3H/He mice varies with the irradiation condition. Radiat Res 1987; 109: 352-4.
15. Nakajima S, Takemura T, Sakata I. Tumor-localizing activity of porphyrin and its affinity to LDL, transferrin. Cancer Lett 1995; 92: 113-8.
16. 99mTc-labeled STA-R12 for tumor imaging. Jpn J Nucl Med 1994; 31: 1379-83.
17. Takemura T, Nakajima S, Sakata I. Critical importance of the triplet lifetime of photosensitizer in photo dynamic therapy of tumor. Photochem Photobiol 1989; 50: 339-44.
18. 4). Magn Reson Med 1987; 4: 252-60.